Biotech campus at McMaster Innovation Park billed as job creator, pandemic fighter
Seventeen years ago this month, The Spectator quoted a consultant who predicted it would take decades for Hamilton to develop a bioscience technology sector, due to a lack of available land, and because companies weren’t knocking down the city’s door to be “anchor tenants.” But news out of McMaster Innovation Park suggests it’s anchors aweigh […]
Bacteria-Fighting RepelWrap Wins ‘Create the Future’ Design Contest
A research team at McMaster University has developed a self-cleaning surface that instantly repels viruses and bacteria – and could potentially prevent the transfer of superbugs (strains of bacteria resistant to most antibiotics). The transparent flexible film can be shrink-wrapped to fit onto door handles, railings, and other surfaces that act as magnets for bacteria. […]
Hamilton-based HT Productions Inc. (Whitebird) receives $3.9 million in FedDev federal funding
Hamilton-based packaging manufacturer and supplier HT Productions Inc. will receive $3.9 million in federal funding that will create nearly 50 new skilled jobs in the city. Speaking to The Spectator on Monday, Economic Development Minister Mélanie Joly said the company will be able to expand its facility and “adopt a more customer-centric online system” with […]
CPDC to produce critical medical radioisotopes for Isotopia Molecular
Israel-based Isotopia Molecular Imaging and CPDC (Hamilton, Ontario) are pleased to announce that they have entered into an agreement for the production and distribution of no-carrier-added Lutetium-177 (n.c.a. Lu-177), a critical medical radioisotope used in the manufacturing of radiopharmaceuticals for treatment of many types of cancer, including neuroendocrine tumors and prostate cancer. The Centre for […]
Fusion Pharmaceuticals Announces Collaboration with AstraZeneca on Next-Generation Radiopharmaceuticals Therapies
Fusion Pharmaceuticals Inc., a Hamilton, Ontario-based clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced a collaboration with AstraZeneca to develop and commercialize next-generation alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. The collaboration leverages Fusion’s Targeted Alpha Therapies (TATs) platform and expertise in radiopharmaceuticals with AstraZeneca’s leading portfolio […]